"Immunity, Mucosal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Nonsusceptibility to the pathogenic effects of foreign microorganisms or antigenic substances as a result of antibody secretions of the mucous membranes. Mucosal epithelia in the gastrointestinal, respiratory, and reproductive tracts produce a form of IgA (IMMUNOGLOBULIN A, SECRETORY) that serves to protect these ports of entry into the body.
| Descriptor ID |
D018928
|
| MeSH Number(s) |
G12.450.573
|
| Concept/Terms |
Immune Response, Mucosal- Immune Response, Mucosal
- Immune Responses, Mucosal
- Mucosal Immune Response
- Mucosal Immune Responses
|
Below are MeSH descriptors whose meaning is more general than "Immunity, Mucosal".
Below are MeSH descriptors whose meaning is more specific than "Immunity, Mucosal".
This graph shows the total number of publications written about "Immunity, Mucosal" by people in this website by year, and whether "Immunity, Mucosal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 3 | 4 |
| 1998 | 1 | 1 | 2 |
| 1999 | 1 | 1 | 2 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 1 | 2 |
| 2002 | 1 | 2 | 3 |
| 2007 | 0 | 3 | 3 |
| 2008 | 3 | 1 | 4 |
| 2009 | 0 | 3 | 3 |
| 2010 | 1 | 1 | 2 |
| 2011 | 0 | 2 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 2 | 3 | 5 |
| 2014 | 2 | 2 | 4 |
| 2015 | 1 | 1 | 2 |
| 2017 | 1 | 2 | 3 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 1 | 2 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 1 | 1 |
| 2023 | 1 | 3 | 4 |
| 2024 | 1 | 1 | 2 |
| 2025 | 1 | 2 | 3 |
| 2026 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunity, Mucosal" by people in Profiles.
-
Weaning drives microbiome-mediated epigenetic regulation to shape immune memory in mice. Nat Microbiol. 2026 Apr; 11(4):1064-1079.
-
Heterologous prime-pull mucosal vaccination with an adjuvanted RBD vaccine elicits robust IgA production and protects against SARS-CoV-2. Front Immunol. 2025; 16:1673460.
-
Mucosal Vaccination With Recombinant Tm-WAP49 Protein Induces Protective Humoral and Cellular Immunity Against Experimental Trichuriasis in AKR Mice. Front Immunol. 2022; 13:800295.
-
Epithelial cell specific Raptor is required for initiation of type 2 mucosal immunity in small intestine. Sci Rep. 2017 07 17; 7(1):5580.
-
Amplified and persistent immune responses generated by single-cycle replicating adenovirus vaccines. J Virol. 2015 Jan; 89(1):669-75.
-
Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV. PLoS One. 2013; 8(7):e67574.
-
Alpha-galactosylceramide is an effective mucosal adjuvant for repeated intranasal or oral delivery of HIV peptide antigens. Vaccine. 2009 May 26; 27(25-26):3335-41.
-
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature. 2009 Feb 05; 457(7230):722-5.
-
Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules. Vaccine. 2007 Dec 17; 25(52):8687-701.
-
Intranasal immunization with synthetic peptides corresponding to the E6 and E7 oncoproteins of human papillomavirus type 16 induces systemic and mucosal cellular immune responses and tumor protection. Vaccine. 2007 Apr 30; 25(17):3302-10.